Search

Search Results
Results 18381 - 18390 of 18402 for breast cancer
  • Rabeprazole Mylan
    Drug - 22 Jan 2021
    Consumer Medicine Information (CMI) about Rabeprazole Mylan (rabeprazole sodium) intended for persons living in Australia.
  • Lecteva
    Drug - 15 Oct 2020
    Consumer Medicine Information (CMI) about Lecteva (levodopa/carbidopa/entacapone) intended for persons living in Australia.
  • Crinone
    Drug - 19 May 2020
    Consumer Medicine Information (CMI) about Crinone intended for persons living in Australia.
  • Sodium Bicarbonate
    Drug - 7 Apr 2020
    Consumer Medicine Information (CMI) about Sodium Bicarbonate intended for persons living in Australia.
  • Cefepime Alphapharm
    Drug - 29 Jul 2019
    Consumer Medicine Information (CMI) about Cefepime Alphapharm (cefepime hydrochloride) intended for persons living in Australia.
  • Test document
    Drug - 17 Jan 2019
    Consumer Medicine Information (CMI) about Test document (darbepoetin alfa) intended for persons living in Australia.
  • Amaryl
    Drug - 29 Aug 2016
    Consumer Medicine Information (CMI) about Amaryl (glimepiride) intended for persons living in Australia.
  • Update on Sudan I contamination
    News - 22 Feb 2005
    The Food Standards Agency has released an update on food products contaminated with the illegal dye Sudan I.
  • Sino Biological Inc.
    Supplier - 11 Mar 2021
    Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development.
  • 3rd HER2-Targeted Therapies Summit
    Supplier - 27 Jul 2023
    The astonishing successes that are Herceptin and Enhertu have demonstrated what the gold standard looks like for ADCs and immunotherapy alike in Breast cancer.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback